In alignment with Jasper's clinical development plan, Jasper obtained regulatory clearance to enroll a 180mg dose cohort (n=12) in the SPOTLIGHT study, which is open and enrolling patients. Jasper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback